Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
50.9 PLN | -0.20% |
|
+0.39% | -11.48% |
May. 17 | Transcript : Ryvu Therapeutics S.A. - Special Call | |
Mar. 13 | Ryvu Therapeutics S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Sales per Business
PLN in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Novel Small Molecule Therapies
100.0
%
| 39 | 100.0 % | 47 | 100.0 % | +20.32% |
Sales per region
PLN in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
European Union Countries
88.9
%
| 25 | 63.2 % | 42 | 88.9 % | +69.25% |
Other Countries
11.0
%
| 14 | 36.5 % | 5 | 11.0 % | -63.73% |
Poland
0.1
%
| 0 | 0.3 % | 0 | 0.1 % | -64.15% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 06-12-31 | |
Hendrik Nogai
CTO | Chief Tech/Sci/R&D Officer | - | 22-01-31 |
Chief Operating Officer | 38 | 12-12-31 | |
Chief Tech/Sci/R&D Officer | - | 06-12-31 | |
Vatnak Vat-Ho
PRN | Corporate Officer/Principal | - | 21-04-25 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 72 | - | |
Scott Fields
BRD | Director/Board Member | 69 | 23-06-13 |
Thomas Turalski
BRD | Director/Board Member | - | - |
Rafal Chwast
BRD | Director/Board Member | - | - |
Piotr Romanowski
CHM | Chairman | - | 18-12-31 |
Director/Board Member | 64 | 19-09-30 | |
Peter Smith
BRD | Director/Board Member | - | 23-06-13 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 23,120,148 | 14,971,047 ( 64.75 %) | 317 ( 0.001371 %) | 64.75 % |
Company contact information
![address Ryvu Therapeutics S.A.(RVU)](https://cdn.zonebourse.com/static/address/19156501.png)
Sector
Sales per region
![Consensus](/images/consensus_flch.gif)
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.65% | 303M | |
+20.63% | 127B | |
+24.89% | 27.67B | |
-20.17% | 20.33B | |
-16.66% | 16.79B | |
-18.07% | 15.63B | |
-47.70% | 14.65B | |
+11.92% | 14.84B | |
+58.32% | 14.43B | |
+149.98% | 12.49B |
- Stock Market
- Equities
- RVU Stock
- Company Ryvu Therapeutics S.A.